ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Endonovo Therapeutics Inc (ID)

Endonovo Therapeutics Inc (ID) (ENDV)

0,0001
0,00
(0,00%)
Geschlossen 11 Juni 10:00PM

Endonovo Therapeutics Inc (ID) (ENDV) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,0001
( - )
Gebot
0,0001
Fragen
0,0001
Volumen
1.016
0,0001 Tagesbereich 0,0001
0,000001 52-Wochen-Bereich 0,0003
Marktkapitalisierung
Handelsende
0,0001
Handelsbeginn
0,0001
Letzte Trade
1000
@
0.0001
Letzter Handelszeitpunkt
Finanzvolumen
US$ 0
VWAP
0,0001
Durchschnittliches Volumen (3 Mio.)
US$ 1.605.712
Ausgegebene Aktien
1.807.556.313
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0
Gewinn pro Aktie (EPS)
-0,06
Erlöse (LTM)
255,72k
Nettogewinn (LTM)
-4,4M

Über Endonovo Therapeutics Inc (ID)

Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of so... Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Woodland Hills, United States
Gegründet
2026
Endonovo Therapeutics Inc (ID) is listed in the Healthcare sector of the OTC Markets with ticker ENDV. The last closing price for Endonovo Therapeutics (ID) was US$0,00. Over the last year, Endonovo Therapeutics (ID) shares have traded in a share price range of US$ 0,000001 to US$ 0,0003.

Endonovo Therapeutics (ID) currently has 1.807.556.313 shares in issue. The market capitalisation of Endonovo Therapeutics (ID) is US$180.755,63 . Endonovo Therapeutics (ID) has a price to earnings ratio (PE ratio) of -0.00.

ENDV Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.00010.00010.00013332400.0001CS
49.9E-599001.0E-60.00011.0E-66846199.968E-5CS
125.0E-51005.0E-50.00011.0E-613287539.514E-5CS
26000.00010.00011.0E-621847969.141E-5CS
52000.00010.00031.0E-675265710.0001154CS
156-0.0169-99.41176470590.0170.01781.0E-667342640.00040418CS
260-0.03145-99.68304278920.031550.061.0E-639506460.00091221CS

ENDV - Frequently Asked Questions (FAQ)

What is the current Endonovo Therapeutics Inc (ID) share price?
The current share price of Endonovo Therapeutics Inc (ID) is US$ 0,0001
How many Endonovo Therapeutics Inc (ID) shares are in issue?
Endonovo Therapeutics Inc (ID) has 1.807.556.313 shares in issue
What is the market cap of Endonovo Therapeutics Inc (ID)?
The market capitalisation of Endonovo Therapeutics Inc (ID) is USD 180,76k
What is the 1 year trading range for Endonovo Therapeutics Inc (ID) share price?
Endonovo Therapeutics Inc (ID) has traded in the range of US$ 0,000001 to US$ 0,0003 during the past year
What is the PE ratio of Endonovo Therapeutics Inc (ID)?
The price to earnings ratio of Endonovo Therapeutics Inc (ID) is -0
What is the cash to sales ratio of Endonovo Therapeutics Inc (ID)?
The cash to sales ratio of Endonovo Therapeutics Inc (ID) is 0,71
What is the registered address of Endonovo Therapeutics Inc (ID)?
The registered address for Endonovo Therapeutics Inc (ID) is 6320 Canoga Avenue, Woodland Hills, California, 91367
What is the Endonovo Therapeutics Inc (ID) website address?
The website address for Endonovo Therapeutics Inc (ID) is www.endonovo.com
Which industry sector does Endonovo Therapeutics Inc (ID) operate in?
Endonovo Therapeutics Inc (ID) operates in the Biotechnology & Life Sciences sector

ENDV Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen